Medicine and Dentistry
Assay
100%
Patient
87%
Thrombin
85%
Biological Marker
82%
Activated Protein C Resistance
80%
Plasma
71%
Hemostat
50%
Donor
49%
Contraceptive Agent
47%
Thrombosis
47%
Procoagulant
47%
Inpatient
44%
Acute Leukemia
44%
Cells
44%
microRNA
38%
Malignant Neoplasm
38%
Disseminated Intravascular Coagulation
38%
Woman
38%
Oral Contraceptive
38%
Septic Shock
38%
Acute Myeloid Leukemia
38%
Leukemia Cell
38%
Nucleosome
38%
Observational Study
38%
COVID-19
38%
Vascular Endothelium
38%
Betrixaban
38%
Multidrug Resistance
38%
Blood Stasis
38%
Metabolism
38%
Postmenopause
38%
HL60
38%
Estetrol
38%
Bone Turnover
38%
Placebo
38%
Drug Resistance
31%
Histone
28%
Antithrombotic
28%
Heparin
28%
Thromboplastin
27%
Therapeutic Procedure
24%
Lipid
21%
Activated Protein C
20%
Factor V Leiden
20%
APC
19%
Coagulation
19%
Neutrophil
19%
Blood Clotting Factor 10a Inhibitor
19%
Endothelial Cell
19%
Cell Adhesion Molecule
19%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Protein C Resistance
76%
Thrombin
55%
Acute Leukemia
51%
Clotting Time
45%
Multiple Drug Resistance
38%
Edoxaban
38%
Betrixaban
38%
Disseminated Intravascular Clotting
38%
Clinical Study
38%
Paroxysmal Nocturnal Hemoglobinuria
38%
Eculizumab
38%
microRNA
38%
Acute Myeloid Leukemia
38%
Multidrug Resistance Protein 1
38%
Procoagulant
38%
DNA Methyltransferase 3A
38%
Histone Methyltransferase
38%
Diffuse Large B Cell Lymphoma
38%
Prothrombin
32%
Malignant Neoplasm
25%
Cytomegalovirus
25%
Venous Thromboembolism
19%
Heparin
19%
Blood Clotting Factor 10a Inhibitor
19%
Estrogen Receptor
19%
Thromboplastin
16%
Activated Protein C
15%
Blood Clotting Factor 5 Leiden
15%
Anticoagulant Agent
15%
Remission
14%
Promyelocytic Leukemia
12%
Buffer
12%
Relapse
12%
Low Molecular Weight Heparin
12%
microRNA 20a
12%
Circulating microRNA
12%
Phospholipid
12%
Biological Marker
12%
Fondaparinux
12%
Nucleic Acid
12%
Luciferase
12%
Cell Death
12%
Lysine
12%
Histone H3
12%
Amine
12%
Quinazoline
12%
DNA Methyltransferase
12%
Lymphoma
12%
Methyltransferase
12%
DNA (Cytosine 5) Methyltransferase 1
12%
Nursing and Health Professions
Thrombin
76%
Standardization
47%
APC
38%
Edoxaban
38%
Sample
38%
Eculizumab
38%
Woman
38%
Placebo
38%
Bone Turnover
38%
Estetrol
38%
Paroxysmal Nocturnal Hemoglobinuria
38%
Pathophysiology
38%
Anticoagulant Agent
31%
Analyzer
28%
Lipid
21%
Parameters
20%
Patient
19%
Blood Clotting Time
16%
Carbohydrate
16%
Procoagulant
14%
Thrombocyte Free Plasma
14%
Reproducibility
11%
Fibrinolytic Agent
10%
Sex Hormone Binding Globulin
10%
Flow Cytometry
9%
Low Molecular Weight Heparin
9%
Laboratory
9%
Experiment
9%
Time
9%
Control
9%
Temperature
9%
Steroid
7%
Marker
5%
Maximum Concentration
5%
Minimum Concentration
5%
Thromboelastograph
5%
Coagulometer
5%
Osteocalcin
5%
Collagen Type 1
5%
Telopeptide
5%
High Density Lipoprotein Cholesterol
5%
Hemoglobin A1c
5%
Activated Protein C
5%
Insulin Resistance
5%